Companies: 10,795·Total market cap: $144.5T
Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG.CNCNQHealthcare● Active
$96.12
$-6.55(-6.38%)
Market Cap$746036822
P/E Ratio
52W High$170
52W Low$33.01
Overview

Bright Minds Biosciences Inc. (DRUG.CN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · DRUG.CN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.39drug.cn eps ttm · drug.cn earnings per shareEarnings history
PE Ratio (TTM)drug.cn pe ratio ttm · drug.cn price to earningsPE Ratio deep dive
Revenue (TTM)0.00drug.cn revenue ttm · drug.cn annual revenueFull revenue history
Dividend YieldNo Dividenddoes drug.cn pay dividends · drug.cn dividend yieldDividend history
Shares Outstanding6.9Mdrug.cn shares outstanding · drug.cn floatShares outstanding history
Next EarningsAug 13, 2026Est.drug.cn earnings date · drug.cn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
bright minds biosciences inc. revenue · drug.cn revenue 2025
FY 2025Net Income-$12.2M▼ 336.46% YoY
202320242025
bright minds biosciences inc. net income · drug.cn profit 2025
FY 2025EPS$-1.78▼ 173.85% YoY
202320242025
drug.cn eps · bright minds biosciences inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$27.5MEPS: $-3.39View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis drug.cn a buy · drug.cn analyst rating
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$96.12Current
$Avg Target
$High
drug.cn price target · drug.cn 12 month forecast

Total: 4 · Buy rate: 100.0%

Stock Performance

Full History
1D-6.38%
1W-10.42%
1M-14.56%
3M-6.42%
YTD-12.96%
1Y+151.16%
5Y+256.66%

About Bright Minds Biosciences Inc.

CEOIan McDonald
IPO DateFeb 9, 2021
Employees26
CountryCA

Bright Minds Biosciences Inc. a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selecti…

what is bright minds biosciences inc. · drug.cn stock overview · bright minds biosciences inc. company profile · who is bright minds biosciences inc. ceo · drug.cn CNQ · bright minds biosciences inc. headquarters · bright minds biosciences inc. business segments

About Stock Overview & Key Data

Bright Minds Biosciences Inc. (DRUG.CN) is a Healthcare company in the Biotechnology industry, listed on CNQ since Feb 9, 2021. As of the latest trading session, DRUG.CN stock price is $96.12, with a market capitalization of $746.0M. The stock has returned +151.16% over the past 12 months and -12.96% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Bright Minds Biosciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Bright Minds Biosciences Inc. reported revenue of — and net income of -$12.2M. For detailed data — including Bright Minds Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bright Minds Biosciences Inc. (DRUG.CN) stock price is $96.12. The stock is traded on CNQ under the ticker symbol DRUG.CN. The 52-week range is $33.01 – $170.00.

DRUG.CN stock priceDRUG.CN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice